Pharmaceutics International, Inc. Reports Major Data Breach Exposing Sensitive PII Pharmaceutics International, Inc. (Pii), a prominent contract development and manufacturing organization in the pharmaceutical sector, has disclosed a significant data breach involving highly sensitive personally identifiable information (PII). The incident was reported to the Massachusetts Attorney General’s office on December 23, 2025, with at least five Massachusetts residents confirmed impacted—though the total number of affected individuals may rise as the investigation continues. The breach exposed a broad range of personal data, including full names, Social Security numbers, dates of birth, current and former addresses, government-issued IDs, Social Security cards, pay stubs, and W-2 forms. The scope of the exposed information heightens the risk of identity theft and financial fraud, though the company has not yet identified the attack vector or responsible threat actor. In response, Pii secured its systems, initiated a comprehensive incident review, and is reassessing its security protocols to prevent future breaches. Regulatory notifications have been filed as required by law. Affected individuals are being offered complimentary credit monitoring and identity protection services through Kroll, along with a dedicated call center for inquiries (844-354-1388, Monday–Friday, 9 a.m.–6:30 p.m. ET). The investigation remains ongoing, with no further details on the breach’s origin or potential broader impact.